pharmaceutical investing Resverlogix Announces Delay in Filing of Annual Financial Statements, AIF, and MD&A
Quebec Innovative Materials Corp. Announces U.S. Affiliate Orvian Receives Minnesota DNR Registration for Exploratory Boring
